BioMed Central, an open access, peer-reviewed journal, has selected to feature research conducted by UTS Pharmacy academic Associate Professor Mary Bebawy.
Bebawy's research reports on the discovery of a new cellular basis for immune evasion, which is mediated by breast cancer derived microparticles.